Journal of Clinical Endocrinology & Metabolism, Vol 47, 119-125, Copyright © 1978 by Endocrine Society

ARTICLES

Progesterone effects on gonadotropin release in women pretreated with estradiol

RJ Chang and RB Jaffe

This study was designed to investigate whether the amounts of progesterone (P) normally present at midcycle, when administered to normal women pretreated with estradiol benzoate (E2B), alter the release of LH and FSH. Twelve subjects (four groups of three) were studied during two menstrual cycles. On day 1 of both the initial (E2 control) and a subsequent (study) cycle, each subject received E2B im (2.5 micrograms/kg/12 h) for a total of seven injections. Twelve hours after the final injection, gonadotropin-releasing hormone (GnRH) was given. In the study cycle, P in oil was added to each of the last three injections of E2B in doses of 1.25 (group I), 2.5 (group II), or 5.0 (group III) mg/12 h, and in one group (IV) in graded doses of 1.25 2.5, and 5.0 mg/12 h. Estradiol levels were similar in both cycles, with a mean (+/- SE) of 271 +/- 3 pg/ml. During the interval of P administration, mean P levels rose gradually from 0.3 +/- 0.02 to 1.3 +/-0.12 ng/ml (mean +/- SE of all groups). In the study cycle, an FSH rise occurred in 8 of 12 subjects, while an LH surge greater than that in the E2 control cycle occurred in all but one subject. Peak levels of these surges usually occurred within 24 h of the initial P injection, which is similar to the relationship between the initial rise of P and the occurrence of peak gonadotropin levels at midcycle in normal women. The mean delta max of FSH and LH in subjects exhibiting gonadotropin rises approximated the magnitude of the gonadotropin increases observed normally at midcycle. In response to GnRH during the study cycle, the magnitude of the FSH rise was augmented in 6 of 12 subjects and of LH in 9 of 12, when compared to the E2 control cycles. These data suggest that P, in the presence of late follicular phase levels of E2, 1) augments the release of LH, 2) may induce the release of FSH, and 3) further modulates pituitary responsiveness to GnRH. The data are consistent with the hypothesis that the rising concentrations of E2 to which the hypothalamic-pituitary system is exposed for an appropriate duration serve to initiate the surge of LH at midcycle. This increased LH in turn, stimulates the production of P, which not only further augments the LH surge but, when coupled with E2, also can effect the midcycle FSH surge.

This article has been cited by other articles:

				C. R. McCartney, S. K. Blank, and J. C. Marshall Progesterone acutely increases LH pulse amplitude but does not acutely influence nocturnal LH pulse frequency slowing during the late follicular phase in women Am J Physiol Endocrinol Metab, March 1, 2007; 292(3): E900 - E906. [Abstract] [Full Text] [PDF]

				J. L Turgeon and D. W Waring Differential expression and regulation of progesterone receptor isoforms in rat and mouse pituitary cells and L{beta}T2 gonadotropes. J. Endocrinol., September 1, 2006; 190(3): 837 - 846. [Abstract] [Full Text] [PDF]

				I. E. Messinis Ovarian feedback, mechanism of action and possible clinical implications Hum. Reprod. Update, September 1, 2006; 12(5): 557 - 571. [Abstract] [Full Text] [PDF]

				K. Dafopoulos, I. Mademtzis, P. Vanakara, A. Kallitsaris, G. Stamatiou, C. Kotsovassilis, and I. E. Messinis Evidence That Termination of the Estradiol-Induced Luteinizing Hormone Surge in Women Is Regulated by Ovarian Factors J. Clin. Endocrinol. Metab., February 1, 2006; 91(2): 641 - 645. [Abstract] [Full Text] [PDF]

				J. W. Hill, J. H. Urban, M. Xu, and J. E. Levine Estrogen Induces Neuropeptide Y (NPY) Y1 Receptor Gene Expression and Responsiveness to NPY in Gonadotrope-Enriched Pituitary Cell Cultures Endocrinology, May 1, 2004; 145(5): 2283 - 2290. [Abstract] [Full Text] [PDF]